Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profilePhillip M. Devlin, M.D.

TitleAssociate Professor of Radiation Oncology
InstitutionBrigham and Women's Hospital
DepartmentRadiation Oncology
AddressBrigham and Women's Hospital
Radiation Oncology, L2
75 Francis St
Boston MA 02115
Phone617/732-6310
Fax617/278-6988
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
Comparison of two dose-fractionation schemes in toxicity, efficacy, and cosmesis for early stage, low risk breast cancer patients undergoing MammoSite accelerated partial breast irradiation
Summer, 06/16/08 - 12/19/08
Family Hisotry, TP53, and MDM2 in Childhood Cancer Survivors
Summer, 06/18/07 - 08/10/07

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Mangione FM, Jatene T, Eslam RB, Bergmark BA, Gallagher JR, Shah PB, Mauri L, Leopold JA, Sobieszczyk PS, Faxon DP, Croce KJ, Bhatt DL, Devlin PM. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. Am J Cardiol. 2017 May 10. PMID: 28583681.
    View in: PubMed
  2. Pinard J, Vleugels RA, Kurtzman DJ, Devlin PM, Patel M. Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau. JAMA Dermatol. 2017 Apr 01; 153(4):331-332. PMID: 28122079.
    View in: PubMed
  3. Damato AL, Buzurovic I, Bhagwat MS, Cormack RA, Devlin PM, Friesen S, Hansen J, Lee LJ, Manuel MM, Cho LP, O'Farrell D, Viswanathan AN. The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy. Brachytherapy. 2017 May - Jun; 16(3):579-585. PMID: 28256433.
    View in: PubMed
  4. Ho KJ, Devlin PM, Madenci AL, Semel ME, Gravereaux EC, Nguyen LL, Belkin M, Menard MT. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis. J Vasc Surg. 2017 Mar; 65(3):734-743. PMID: 27986482.
    View in: PubMed
  5. Likhacheva AO, Devlin PM, Shirvani SM, Barker CA, Beron P, Bhatnagar A, Doggett SW, Hochman L, Hsu C, Kasper M, Keisch M, Mutyala S, Prestidge B, Rodriguez Villalba S, Shukla V, Sundararaman S, Kamrava M. Skin surface brachytherapy: A survey of contemporary practice patterns. Brachytherapy. 2017 Jan - Feb; 16(1):223-229. PMID: 27908679.
    View in: PubMed
  6. Cho LP, Manuel M, Catalano P, Lee L, Damato AL, Cormack RA, Buzurovic I, Bhagwat M, O'Farrell D, Devlin PM, Viswanathan AN. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience. Gynecol Oncol. 2016 Dec; 143(3):545-551. PMID: 27720445.
    View in: PubMed
  7. Buzurovic IM, Hansen JL, Bhagwat MS, O'Farrell DA, Friesen S, Harris TC, Damato AL, Cormack RA, Martin NE, Devlin PM. Clinical implementation of a novel applicator in high-dose-rate brachytherapy treatment of esophageal cancer. J Contemp Brachytherapy. 2016 Aug; 8(4):319-25. PMID: 27648086.
    View in: PubMed
  8. Paul S, Bach D, LeBoeuf NR, Devlin PM, Lipworth AD. Successful use of brachytherapy for a severe hidradenitis suppurativa variant. Dermatol Ther. 2016 Nov; 29(6):455-458. PMID: 27425163.
    View in: PubMed
  9. Damato A, Devlin P, Bhagwat M, Buzurovic I, Hansen J, O'Farrell D, Cormack R. WE-DE-201-11: Sensitivity and Specificity of Verification Methods Based On Total Reference Air Kerma (TRAK) Or On User Provided Dose Points for Graphically Planned Skin HDR Brachytherapy. Med Phys. 2016 Jun; 43(6):3810-3811. PMID: 28048473.
    View in: PubMed
  10. Buzurovic I, Devlin P, Hansen J, O'Farrell D, Bhagwat M, Friesen S, Damato A, Harris T, Cormack R. SU-G-201-04: Can the Dynamic Library of Flap Applicators Replace Treatment Planning in Surface Brachytherapy? Med Phys. 2016 Jun; 43(6):3623. PMID: 28047025.
    View in: PubMed
  11. Timerman D, Devlin PM, Nambudiri VE, Wright NA, Vleugels RA, Clark RA, Kupper TS, Merola JF, Patel M. Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. Clin Exp Dermatol. 2016 Jul; 41(5):498-501. PMID: 26848819.
    View in: PubMed
  12. Goddard AL, Vleugels RA, LeBoeuf NR, O'Farrell DA, Cormack RA, Hansen JL, Kupper TS, Devlin PM. Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. JAMA Dermatol. 2015 Dec 01; 151(12):1354-1357. PMID: 26397774.
    View in: PubMed
  13. Stewart A, Parashar B, Patel M, O'Farrell D, Biagioli M, Devlin P, Mutyala S. American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. Brachytherapy. 2016 Jan-Feb; 15(1):1-11. PMID: 26561277.
    View in: PubMed
  14. Abou Al-Shaar H, Almefty KK, Abolfotoh M, Arvold ND, Devlin PM, Reardon DA, Loeffler JS, Al-Mefty O. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas. J Neurooncol. 2015 Sep; 124(3):515-22. PMID: 26253325.
    View in: PubMed
  15. Wagar M, Bhagwat M, O'Farrell D, Friesen S, Buzurovic I, Damato A, Devlin P, Cormack R. SU-E-T-413: Examining Acquisition Rate for Using MatriXX Ion Chamber Array to Measure HDR Brachytherapy Treatments. Med Phys. 2015 Jun; 42(6):3429. PMID: 26128080.
    View in: PubMed
  16. Buzurovic I, Hansen J, Bhagwat M, O'Farrell D, Damato A, Friesen S, Devlin P, Cormack R. SU-E-T-165: Characterization of Dose Distributions in High-Dose-Rate Surface Brachytherapy. Med Phys. 2015 Jun; 42(6):3369. PMID: 26127828.
    View in: PubMed
  17. Sugar EN, Buzurovic I, O'Farrell D, Hansen J, Devlin P, Cormack R, Nguyen P. SU-E-T-301: Dosimetric Comparison Between Adaptive and Rectilinear Template-Based Prostate Seed Implants. Med Phys. 2015 Jun; 42(6):3402. PMID: 26127964.
    View in: PubMed
  18. Bhagwat M, O'Farrell D, Wagar M, Buzurovic I, Friesen S, Damato A, Devlin P, Cormack R. SU-E-T-783: Using Matrixx to Determine Transit Dose Contribution Over Clinically Useful Limits of HDR Source Activity. Med Phys. 2015 Jun; 42(6):3517. PMID: 26128445.
    View in: PubMed
  19. Muralidhar V, Mahal BA, Ziehr DR, Chen YW, Nezolosky MD, Viswanathan VB, Beard CJ, Devlin PM, Martin NE, Orio PF, Nguyen PL. Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. Brachytherapy. 2015 Jul-Aug; 14(4):511-6. PMID: 25887342.
    View in: PubMed
  20. Lane JD, Pomahac B, Raut CP, Baldini EH, Devlin PM. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229. PMID: 25426346; PMCID: PMC4236374.
  21. Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63. PMID: 25341749.
    View in: PubMed
  22. Damato AL, Devlin PM, Bhagwat MS, Buzurovic I, Friesen S, Hansen JL, Lee LJ, Molodowitch C, Nguyen PL, O'Farrell DA, Viswanathan AN, Williams CL, Killoran JH, Cormack RA. Independent brachytherapy plan verification software: improving efficacy and efficiency. Radiother Oncol. 2014 Dec; 113(3):420-4. PMID: 25458129.
    View in: PubMed
  23. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr TR, Suh WW, Devlin PM, Tempany CM, Sugar EH, O'Farrell DA, Steele G, O'Leary M, Buzurovic I, Damato AL, Cormack RA, Fedorov AY, Nguyen PL. Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. Radiat Oncol. 2014 Sep 09; 9:200. PMID: 25205146; PMCID: PMC4261899.
  24. Buzurovic I, Devlin P, Hansen J, O' Farrell D, Bhagwat M, Friesen S, Damato A, Lewis J, Cormack R. SU-E-T-362: Automatic Catheter Reconstruction of Flap Applicators in HDR Surface Brachytherapy. Med Phys. 2014 Jun; 41(6):308. PMID: 28037929.
    View in: PubMed
  25. Damato AL, Bhagwat MS, Buzurovic I, Devlin PM, Friesen S, Hansen JL, Kapur T, Lee LJ, Mehrtash A, Nguyen PL, O' Farrell D, Wang W, Viswanathan AN, Cormack RA. WE-A-17A-03: Catheter Digitization in High-Dose-Rate Brachytherapy with the Assistance of An Electromagnetic (EM) Tracking System. Med Phys. 2014 Jun; 41(6):487-488. PMID: 28037155.
    View in: PubMed
  26. Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Brachytherapy. 2014 Sep-Oct; 13(5):442-9. PMID: 24880584.
    View in: PubMed
  27. Nguyen PL, Hyatt AS, Devlin PM. PSA screening: the case in favor. Oncology (Williston Park). 2013 Oct; 27(10):980, 982. PMID: 24367854.
    View in: PubMed
  28. Stewart AJ, Hepel JT, O'Farrell DA, Devlin PM, Price LL, Dale RG, Wazer DE. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Radiother Oncol. 2013 Aug; 108(2):232-5. PMID: 23891101.
    View in: PubMed
  29. Garibyan L, Cotter SE, Hansen JL, Noell C, Dorosario A, O'Farrell DA, Devlin PM, Wang LC. Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J. 2013 Jul-Aug; 19(4):283-7. PMID: 23867506; PMCID: PMC4131924.
  30. DeSimone JA, Guenova E, Carter JB, Chaney KS, Aldridge JR, Noell CM, Dorosario AA, Hansen JL, Kupper TS, Devlin PM. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2013 Jul; 69(1):61-5. PMID: 23453243.
    View in: PubMed
  31. Holloway CL, Delaney TF, Alektiar KM, Devlin PM, O'Farrell DA, Demanes DJ. American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy. 2013 May-Jun; 12(3):179-90. PMID: 23434220.
    View in: PubMed
  32. McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7. PMID: 23392853.
    View in: PubMed
  33. Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9. PMID: 23242820.
    View in: PubMed
  34. Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR. Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):355-62. PMID: 23040221; PMCID: PMC3545084.
  35. Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. Brachytherapy. 2013 Jan-Feb; 12(1):19-24. PMID: 22819388; PMCID: PMC3518616.
  36. Nguyen PL, Devlin PM, Beard CJ, Orio PF, O'Leary MP, Wolfsberger LD, O'Farrell DA, Sweeney CM, Hadaschik BA, Hohenfellner M, Hatiboglu G. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 2013 Jan-Feb; 12(1):77-83. PMID: 22543116.
    View in: PubMed
  37. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr T, Suh WW, Devlin PM, Tempany CM, Nguyen PL. Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):249. PMID: 28143244.
    View in: PubMed
  38. Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Arch Dermatol. 2011 Jul; 147(7):870-2. PMID: 21768497.
    View in: PubMed
  39. Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):e813-8. PMID: 21300455.
    View in: PubMed
  40. Cotter SE, Devlin PM, Sahni D, Hansen JL, O'Farrell DA, Ng AK, Wang LC. Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. J Clin Oncol. 2010 Sep 20; 28(27):e464-6. PMID: 20679604.
    View in: PubMed
  41. Ahmed HM, Dipiro PJ, Devlin PM, Nguyen ML, Bellon JR. Mammographic appearance following accelerated partial breast irradiation by using MammoSite brachytherapy. Radiology. 2010 May; 255(2):362-8. PMID: 20332376.
    View in: PubMed
  42. Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 2010 May; 83(989):369-78. PMID: 20223911; PMCID: PMC3473572.
  43. Stewart AJ, Devlin PM, Mutyala S. Counterpoint: the dose rate argument--Does size matter after all? Brachytherapy. 2009 Jul-Sep; 8(3):273-5. PMID: 19643374.
    View in: PubMed
  44. Mutyala S, Devlin PM, Stewart AJ. Rebuttal to Drs. Davidson, Hendry, and West: once burned, twice shy? Brachytherapy. 2009 Jul-Sep; 8(3):277. PMID: 19643376.
    View in: PubMed
  45. Mutyala S, Stewart A, Khan AJ, Cormack RA, O'Farrell D, Sugarbaker D, Devlin PM. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1114-20. PMID: 19540065.
    View in: PubMed
  46. Siddiqi NH, Devlin PM. Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report. J Vasc Interv Radiol. 2009 May; 20(5):664-9. PMID: 19328722.
    View in: PubMed
  47. Stewart AJ, Mutyala S, Holloway CL, Colson YL, Devlin PM. Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. Brachytherapy. 2009 Jan-Mar; 8(1):63-9. PMID: 19056322.
    View in: PubMed
  48. Stewart AJ, O'Farrell DA, Cormack RA, Hansen JL, Khan AJ, Mutyala S, Devlin PM. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008 Nov 19; 3:39. PMID: 19019216; PMCID: PMC2612673.
  49. Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM. Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):323-6. PMID: 18793951.
    View in: PubMed
  50. Siddiqi NH, Khan AJ, Devlin PM. Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study. Cardiovasc Intervent Radiol. 2009 Jan; 32(1):47-51. PMID: 18779994.
    View in: PubMed
  51. Cormack RA, Devlin PM. Brachytherapy partial breast irradiation: analyzing effect of source configurations on dose metrics relevant to toxicity. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):940-4. PMID: 18514786.
    View in: PubMed
  52. Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatr Scand. 2008 Apr; 117(4):271-6. PMID: 18307587.
    View in: PubMed
  53. Cormack RA, Holloway CL, O'Farrell D, Devlin PM. Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1310-5. PMID: 17967321.
    View in: PubMed
  54. Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV. Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. Urol Oncol. 2008 Mar-Apr; 26(2):147-52. PMID: 18312933.
    View in: PubMed
  55. Mutyala S, Choi W, Khan AJ, Yaparpalvi R, Stewart AJ, Devlin PM. Inherent change in MammoSite applicator three-dimensional geometry over time. Radiat Oncol. 2007 Sep 24; 2:37. PMID: 17892557; PMCID: PMC2034578.
  56. Rivard MJ, Butler WM, Devlin PM, Hayes JK, Hearn RA, Lief EP, Meigooni AS, Merrick GS, Williamson JF. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy. 2007 Jan-Mar; 6(1):34-7. PMID: 17284383.
    View in: PubMed
  57. Stewart AJ, O'Farrell DA, Mutyala S, Bueno R, Sugarbaker DJ, Cormack RA, Devlin PM. Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. Brachytherapy. 2007 Jan-Mar; 6(1):58-61. PMID: 17284388.
    View in: PubMed
  58. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, Tempany C. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):91-9. PMID: 16839709.
    View in: PubMed
  59. Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect. 2006 May; 52(5):329-34. PMID: 16176833.
    View in: PubMed
  60. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005 Jul 07; 3:27. PMID: 15987522; PMCID: PMC1226180.
  61. Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005 May; 27(5):353-61. PMID: 15726587.
    View in: PubMed
  62. Stewart AJ, O'Farrell DA, Bellon JR, Hansen JL, Duggan C, Czerminska MA, Cormack RA, Devlin PM. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery. Brachytherapy. 2005; 4(3):224-9. PMID: 16182223.
    View in: PubMed
  63. Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up. Am J Clin Oncol. 2004 Aug; 27(4):369-75. PMID: 15289730.
    View in: PubMed
  64. Iftimia I, Devlin PM, Martin AG, Shakur R, Almonacid A, Kazakin J, Chin LM, Cormack RA. Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source. Brachytherapy. 2004; 3(4):215-21. PMID: 15607153.
    View in: PubMed
  65. Iftimia I, Devlin PM, Chin LM, Baron JM, Cormack RA. GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train. Med Phys. 2003 Jun; 30(6):1004-12. PMID: 12852522.
    View in: PubMed
  66. Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002 Jun 01; 53(2):394-400. PMID: 12023144.
    View in: PubMed
  67. Devlin PM, Brus CR, Kazakin J, Mitchell RB, Demanes DJ, Edmundson G, Gribble M, Gustafson GS, Kelly DA, Linares LA, Martinez AA, Mate TP, Nag S, Perez CA, Rao JG, Rodriguez RR, Shasha D, Tripuraneni P. An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):104-15. PMID: 12007948.
    View in: PubMed
  68. Devlin PM, Harrison LB. Brachytherapy for soft tissue sarcomas. Cancer Treat Res. 1997; 91:107-28. PMID: 9286492.
    View in: PubMed
  69. Hata S, Clabby M, Devlin P, Spits H, De Vries JE, Krangel MS. Diversity and organization of human T cell receptor delta variable gene segments. J Exp Med. 1989 Jan 01; 169(1):41-57. PMID: 2521243; PMCID: PMC2189176.
  70. Hata S, Satyanarayana K, Devlin P, Band H, McLean J, Strominger JL, Brenner MB, Krangel MS. Extensive junctional diversity of rearranged human T cell receptor delta genes. Science. 1988 Jun 10; 240(4858):1541-4. PMID: 3259726.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Devlin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_